logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. University Hospital of Zürich

+41442551111
international@usz.ch
Source: Site record.
https://www.usz.ch

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

At University Hospital Zurich (USZ), around 2,500 researchers work across a wide range of fields covering nearly all medical disciplines. We leverage our close collaboration with the University of Zurich and ETH Zurich to develop the latest treatment methods for our patients. These treatments are applied according to strict scientific standards. Some therapies are offered exclusively by USZ among Swiss hospitals.Our employees provide comprehensive and personalized medical care across different specialties. With around 900 hospital beds and nearly 300,000 inpatient care days, USZ is one of the largest hospitals in Switzerland.USZ is open to everyone and provides both general healthcare and highly specialized medicine at a central location in Zurich.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Trial-derived.
105Total Trials
Source: Trial-derived.
30Recruiting Trials
Source: Trial-derived.
45Active Trials
Source: Trial-derived.
51Completed Trials
Source: Trial-derived.
180Unique Conditions
Source: Trial-derived.
147Unique Sponsors

Conditions

Source: Trial-derived. Glioblastoma (3)Source: Trial-derived. Hypoxia (3)Source: Trial-derived. Normobaric Hypoxia (3)Source: Trial-derived. Parkinson Disease (3)Source: Trial-derived. Altitude Hypoxia (2)Source: Trial-derived. Cancer (2)Source: Trial-derived. Coronary Artery Disease (2)Source: Trial-derived. Crohn's Disease (2)

Sponsors

Source: Trial-derived. University of Zurich (35)Source: Trial-derived. University Hospital, Basel, Switzerland (6)Source: Trial-derived. European Organisation for Research and Treatment of Cancer - EORTC (5)Source: Trial-derived. Hoffmann-La Roche (5)Source: Trial-derived. Insel Gruppe AG, University Hospital Bern (4)Source: Trial-derived. Mona Lichtblau (4)Source: Trial-derived. Swiss Cancer Institute (4)Source: Trial-derived. Swiss National Science Foundation (4)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. MRI
Source: AI-inferred. Echocardiography
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI proton density fat fraction
Source: AI-inferred. PET-CT
Source: AI-inferred. Spirometry

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Liver biopsy
Source: AI-inferred. Peripheral angiography and endovascular intervention

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Catheter-based pulmonary artery mechanical thrombectomy
Source: AI-inferred. MGMT analysis
Source: AI-inferred. Multidisciplinary Heart Team assessment
Source: AI-inferred. Renal (kidney) biopsy
Source: AI-inferred. Subcutaneous infusion administration
Source: AI-inferred. Transcatheter mitral valve repair (edge-to-edge clip)
Source: AI-inferred. Tumour proteasome activity testing